D. Pariser

发表

Primary care physicians' errors in handling cutaneous disorders. A prospective survey.

R. Pariser, D. Pariser, R J Pariser, 1987, Journal of the American Academy of Dermatology.

Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA).

D. Pariser, R. Wyles, 1980, Journal of the American Academy of Dermatology.

Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption.

D. Pariser, 2009, American journal of therapeutics.

A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis.

E. Carter, M. Boguniewicz, M. Stiller, 2004, Journal of the American Academy of Dermatology.

Low Systemic Absorption and Good Tolerability of Pimecrolimus, Administered as 1% Cream (Elidel®) in Infants with Atopic Dermatitis – A Multicenter, 3‐Week, Open‐Label Study

A. Gottlieb, H. Schmidli, R. Langley, 2005, Pediatric dermatology.

A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis

A. Gottlieb, G. Scott, D. Pariser, 2005, The Journal of dermatological treatment.

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.

Sewon Kang, S. Kang, A. Lucky, 2001, Journal of the American Academy of Dermatology.

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of VT-1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail.

B. Elewski, J. Schlessinger, M. Gold, 2020 .

Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild-to-moderate distal subungual onychomycosis: A randomized, multi-center, double-blind, vehicle-controlled phase 3 study.

Aditya K. Gupta, D. Pariser, S. Kempers, 2020, Journal of the American Academy of Dermatology.

Diagnosis and Management of Onychomycosis Perspectives from a Joint Podiatric Medicine-Dermatology Roundtable.

A. Tosti, W. Joseph, D. Pariser, 2016, Journal of the American Podiatric Medical Association.

Guidelines of care for superficial mycotic infections of the skin: onychomycosis. Guidelines/Outcomes Committee. American Academy of Dermatology.

B. Elewski, E. Farmer, L. Drake, 1996, Journal of the American Academy of Dermatology.

A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis.

M. Lebwohl, D. Pariser, Binu Alexander, 2017, Journal of drugs in dermatology : JDD.

Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis

K. Papp, H. Valdez, S. Tyring, 2015, BMC Dermatology.

National Psoriasis Foundation clinical consensus on disease severity.

Elizabeth J Horn, B. Strober, M. Lebwohl, 2007, Archives of dermatology.

Guidelines of care for vitiligo. American Academy of Dermatology.

M. Turner, J. Nordlund, E. Farmer, 1996, Journal of the American Academy of Dermatology.

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

G. Yancopoulos, N. Stahl, C. Griffiths, 2017, The Lancet.

Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

A. Gottlieb, L. Naldi, K. Papp, 2015, Journal of drugs in dermatology : JDD.

Integrating Skin Cancer-Related Technologies into Clinical Practice.

D. Rigel, A. Sober, C. Cockerell, 2017, Dermatologic clinics.

OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis.

A. Kimball, A. Menter, J. Gelfand, 2013, Journal of the American Academy of Dermatology.

Ethical considerations in health care reform: pros and cons of the Affordable Care Act.

D. Pariser, 2012, Clinics in dermatology.

From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis.

B. Strober, M. Lebwohl, A. Kimball, 2008, Journal of the American Academy of Dermatology.

Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients.

A. Gottlieb, A. Fleischer, J. Koo, 2005, Journal of the American Academy of Dermatology.

Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis

John D. Davis, G. Yancopoulos, N. Stahl, 2019, JAMA dermatology.

Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS‐1 and ATMOS‐2 phase 3 randomized controlled trials

J. Drew, A. Nast, D. Pariser, 2019, Journal of the American Academy of Dermatology.

Comparison of 15% Azelaic Acid Gel and 0.75% Metronidazole Gel for the Topical Treatment of Papulopustular Rosacea—Reply

B. Elewski, A. Fleischer, D. Pariser, 2004 .

Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis.

A. Gottlieb, K. Papp, K. Gordon, 2012, Journal of the American Academy of Dermatology.

Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis.

A. Paller, D. Collier, G. Kricorian, 2016, Journal of the American Academy of Dermatology.

Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR

B. Strober, A. Gottlieb, K. Papp, 2021, Drug Safety.

A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.

B. Elewski, A. Fleischer, D. Pariser, 2003, Archives of dermatology.

A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.

Y. Poulin, L. Guenther, D. Pariser, 2000, Clinical therapeutics.

Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial.

O. Akilov, O. Donini, T. Kuzel, 2022, JAMA dermatology.

A phase 2a randomized, double‐blind, placebo‐controlled, sequential dose‐escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate‐to‐severe psoriasis

K. Papp, G. Ball, J. Krueger, 2015, The British journal of dermatology.

Etanercept treatment for children and adolescents with plaque psoriasis.

A. Gottlieb, A. Paller, R. Langley, 2008, The New England journal of medicine.

Intermittent etanercept therapy in pediatric patients with psoriasis.

A. Paller, G. Kricorian, L. Eichenfield, 2010, Journal of the American Academy of Dermatology.

Efficacy and safety of etanercept in children and adolescents aged > or = 8 years with severe plaque psoriasis.

A. Paller, G. Kricorian, B. Freundlich, 2010, European journal of dermatology : EJD.

Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail.

J. Leyden, S. Kang, L. Drake, 1998, Journal of the American Academy of Dermatology.

Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail.

M. Lebwohl, J. Leyden, W. Eaglstein, 1998, Journal of the American Academy of Dermatology.

A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis

T. Brown, C. Ellis, C. Carter, 2015, The Journal of dermatological treatment.

OBSERVE-5, an Observational Post-Marketing Safety Surveillance Registry of Etanercept for the Treatment of Psoriasis: A Model for Studying New Psoriasis Therapies

A. Kimball, A. Menter, J. Gelfand, 2010 .

Long-term etanercept in pediatric patients with plaque psoriasis.

A. Paller, G. Kricorian, R. Langley, 2010, Journal of the American Academy of Dermatology.

Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study

M. Gooderham, J. Fowler, R. Bissonnette, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Clinical Efficacy of Efalizumab in Patients With Chronic Plaque Psoriasis: Results From Three Randomized Placebo-Controlled Phase III Trials: Part I

M. Lebwohl, P. Kwon, K. Papp, 2005, Journal of cutaneous medicine and surgery.

The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study†

L. Denis, S. Forman, J. Fowler, 2019, The British journal of dermatology.

Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials

John D. Davis, J. Silverberg, Meng Li, 2019, Journal of drugs in dermatology : JDD.

15340 Long-term treatment with secukinumab led to sustained clinical improvement and normalization of inflammatory markers in patients with psoriasis

A. Armstrong, F. Kianifard, A. Blauvelt, 2020 .

An open-label pilot study of apremilast for the treatment of moderate to severe lichen planus: a case series.

D. Pariser, T. Cunningham, J. Paul, 2013, Journal of the American Academy of Dermatology.

Evolving perspectives on the etiology and pathogenesis of acne vulgaris.

J. Weiss, L. Eichenfield, L. Kircik, 2015, Journal of drugs in dermatology : JDD.

Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE)

M. Ardeleanu, Zhen Chen, J. Chao, 2022, Dermatology and Therapy.

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

N. Rupp, G. Yancopoulos, A. Paller, 2022, The Lancet.

The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.

J. Waldstreicher, D. Thiboutot, L. Drake, 1999, Journal of the American Academy of Dermatology.

Efficacy and safety of the Janus kinase 1 inhibitor PF‐04965842 in patients with moderate‐to‐severe psoriasis: phase II, randomized, double‐blind, placebo‐controlled study

Z. Draelos, E. Peeva, C. Banfield, 2018, The British journal of dermatology.

Incidence of serious gastrointestinal events among tildrakizumab‐treated patients with psoriasis

B. Elewski, M. Gooderham, A. Mendelsohn, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Guidelines of care for superficial mycotic infections of the skin: mucocutaneous candidiasis. Guidelines/Outcome Committee. American Academy of Dermatology.

B. Elewski, E. Farmer, L. Drake, 1996, Journal of American Academy of Dermatology.

Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.

A. Gottlieb, M. Lebwohl, Z. Draelos, 2004, Journal of the American Academy of Dermatology.

Itch: an under‐recognized problem in psoriasis

B. Elewski, M. Lebwohl, G. Yosipovitch, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Facial Soft-Tissue Fillers: Assessing the State of the Science conference---Proceedings report.

Susan C. Taylor, Rod J. Rohrich, J. Carruthers, 2011, Journal of the American Academy of Dermatology.

Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle‐controlled trial

P. Schlievert, R. Langley, D. Leung, 2009, The British journal of dermatology.

Secukinumab Treatment Does Not Alter the Pharmacokinetics of the Cytochrome P450 3A4 Substrate Midazolam in Patients With Moderate to Severe Psoriasis

C. Calonder, R. Woessner, R. Soon, 2019, Clinical pharmacology and therapeutics.

Guidelines of care for scleroderma and sclerodermoid disorders. American Academy of Dermatology.

J. Callen, E. Farmer, L. Drake, 1996, Journal of American Academy of Dermatology.

Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

J. Schlessinger, Y. Poulin, R. Langley, 2017, Dermatology and Therapy.

Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis.

J. Fowler, P. Cruz, R. Langley, 2004, Cutis.

Guidelines of care for local and regional anesthesia in cutaneous surgery. Guidelines/Outcomes Committee: American Academy of Dermatology.

M. Turner, L. Drake, R. Goltz, 1995, Journal of the American Academy of Dermatology.

TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-blind, Placebo-controlled Trial.

E. Peeva, S. Forman, Y. Poulin, 2020, The Journal of investigative dermatology.

Continued treatment with secukinumab is associated with high retention or regain of response

M. Lebwohl, K. Reich, M. Augustin, 2019, The British journal of dermatology.

Photodynamic therapy with methyl aminolaevulinate 80 mg g−1 for severe facial acne vulgaris: a randomized vehicle‐controlled study

L. Eichenfield, D. Pariser, M. Jarratt, 2016, The British journal of dermatology.

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.

M. Lebwohl, Z. Draelos, M. Gooderham, 2022, JAMA.

Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.

Sewon Kang, A. Menter, C. Langman, 2004, Journal of the American Academy of Dermatology.

Daisy Maude Orleman Robinson: the first American woman dermatologist.

D. Pariser, 2015, Clinics in dermatology.

Botulinum toxin in the management of focal hyperhidrosis

D. Pariser, D. Glaser, 2011 .

Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology.

E. Farmer, E. Olsen, L. Drake, 1996, Journal of the American Academy of Dermatology.

Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology.

E. Farmer, E. Olsen, L. Drake, 1996, Journal of the American Academy of Dermatology.

Long‐term safety and efficacy of a fixed‐combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate‐to‐severe plaque psoriasis: phase 3 open‐label study

M. Lebwohl, K. Papp, D. Pariser, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Facial Soft-Tissue Fillers conference: Assessing the State of the Science.

Susan C. Taylor, Rod J. Rohrich, J. Carruthers, 2011, Journal of the American Academy of Dermatology.

Facial soft-tissue fillers conference: assessing the state of the science.

Susan C. Taylor, Rod J. Rohrich, J. Carruthers, 2011, Plastic and reconstructive surgery.

Guidelines of care for contact dermatitis

C. Mathias, W. Jordan, M. Turner, 1995 .

Guidelines of care for superficial mycotic infectionsof the skin: Tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis

B. Elewski, E. Farmer, L. Drake, 1996 .

A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns.

B. Elewski, M. Ghannoum, R. Summerbell, 2000, Journal of the American Academy of Dermatology.

Diagnosis, clinical implications, and complications of onychomycosis.

B. Elewski, D. Pariser, R. Scher, 2013, Seminars in cutaneous medicine and surgery.

Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Guidelines/Outcomes Committee. American Academy of Dermatology.

B. Elewski, E. Farmer, L. Drake, 1996, Journal of the American Academy of Dermatology.

Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.

B. Reyes, M. Klausner, R. Pariser, 1998, Journal of the American Academy of Dermatology.

Onychomycosis: Strategies to Minimize Recurrence.

B. Elewski, A. Tosti, T. Rosen, 2016, Journal of drugs in dermatology : JDD.

Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.

B. Elewski, J. Olin, D. Pariser, 2013, Journal of the American Academy of Dermatology.

Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea cruris.

R. Pariser, D. Pariser, G. Ruoff, 1994, Journal of the American Academy of Dermatology.

The epidemiology, etiology, and pathophysiology of onychomycosis.

B. Elewski, D. Pariser, R. Scher, 2013, Seminars in cutaneous medicine and surgery.

Guidelines of care for superficial mycotic infectionsof the skin: Tinea capitis and tinea barbae

B. Elewski, E. Farmer, L. Drake, 1996 .

Guidelines of care for superficial mycotic of the skin: Tinea capitis and tinea barbae infections

B. Elewski, E. Farmer, R. Goltz, 1996 .

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.

J. Leyden, S. Kang, L. Drake, 1998, Journal of the American Academy of Dermatology.

Managing Onychomycosis : New and Emerging Treatments and Recurrence Prevention Strategies Evaluation Form

D. Pariser, N. Jellinek, P. Rich, 2015 .

Guidelines of care for superficial mycotic infections of the skin: Piedra. Guidelines/Outcomes Committee. American Academy of Dermatology.

B. Elewski, E. Farmer, L. Drake, 1996, Journal of the American Academy of Dermatology.

Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream.

B. Elewski, D. Pariser, E. Tschen, 1997, Journal of the American Academy of Dermatology.

Guidelines of care for superficial mycotic infectionsof the skin: Pityriasis (tinea) versicolor

B. Elewski, E. Farmer, L. Drake, 1996 .

Guidelines of care for superficial mycotic of the skin: Pityriasis (tinea) versicolor infections

B. Elewski, E. Farmer, R. Goltz, 1996 .

Office techniques for diagnosing skin disease

W. Eaglstein, D. Pariser, 1978 .

Guidelines of care for superficial mycotic infections of the skin: Pityriasis (tinea) versicolor. Guidelines/Outcomes Committee. American Academy of Dermatology.

B. Elewski, E. Farmer, L. Drake, 1996, Journal of the American Academy of Dermatology.

Ciclopirox gel in the treatment of patients with interdigital tinea pedis

A. Menter, N. Levine, J. Taylor, 2003, International journal of dermatology.

Finasteride in the treatment of men with frontal male pattern hair loss.

M. Lebwohl, J. Leyden, J. Waldstreicher, 1999, Journal of the American Academy of Dermatology.

An in-office diagnostic procedure to detect dermatophytes in a nationwide study of onychomycosis patients.

D. Pariser, C. Opper, 2002, Managed care.

Superficial fungal infections. A practical guide for primary care physicians.

D. Pariser, 1990, Postgraduate medicine.

Efficacy and safety of efalizumab in a large cohort of patients with moderate to severe plaque psoriasis: pooled results from randomized phase III trials

K. Gordon, R. Langley, D. Pariser, 2004 .

Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

Ann-Marie Wennberg, Peter Foley, Rik Roelandts, 2007, Journal of the American Academy of Dermatology.

Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison.

Z. Draelos, C. Paul, J. Shupack, 2005, Journal of the American Academy of Dermatology.

Topical 0.5% ivermectin lotion for treatment of head lice.

D. Pariser, W. Ryan, M. Bell, 2012, The New England journal of medicine.

The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies

L. C. Fuller, R. Hay, T. Maurer, 2020, The British Journal of Dermatology.

A brief guide to pustular psoriasis for primary care providers

J. Crowley, D. Pariser, P. Yamauchi, 2020, Postgraduate medicine.

Onchomycosis: an overview.

B. Elewski, A. Tosti, Aditya K. Gupta, 2013, Journal of drugs in dermatology : JDD.

Tinea versicolor. A practical guide for primary care physicians.

D. Pariser, 1990, Postgraduate medicine.

Cutaneous candidiasis. A practical guide for primary care physicians.

D. Pariser, 1990, Postgraduate medicine.

Clinical and mycological effect of clotrimazole/betamethasone dipropionate cream versus ketoconazole cream in patients with tinea cruris

R. Pariser, D. Pariser, 1995 .

Guidelines of care for office surgical facilities. Part II. Self-assessment checklist. American Academy of Dermatology.

L. Drake, R. Ceilley, R. Cornelison, 1995, Journal of the American Academy of Dermatology.

Guidelines of care for superficial mycotic infections of the skin: tinea capitis and tinea barbae. Guidelines/Outcomes Committee. American Academy of Dermatology.

B. Elewski, E. Farmer, L. Drake, 1996, Journal of the American Academy of Dermatology.

Current and emerging options in the treatment of onychomycosis.

B. Elewski, D. Pariser, R. Scher, 2013, Seminars in cutaneous medicine and surgery.

Oxiconazole nitrate lotion, 1 percent: an effective treatment for tinea pedis.

R. Pariser, D. Pariser, 1994, Cutis.

Onychomycosis: Does Cure Equate to Treatment Success?

B. Elewski, A. Tosti, T. Rosen, 2016, Journal of drugs in dermatology : JDD.

The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies

L. C. Fuller, R. Hay, T. Maurer, 2020, The British journal of dermatology.

Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies

A. Oseroff, A. Menter, D. Murrell, 2009, International journal of dermatology.

Guidelines of care for Mohs micrographic surgery

M. Turner, S. Salasche, L. Drake, 1995 .

Guidelines of care for Mohs micrographic surgery. American Academy of Dermatology.

M. Turner, S. Salasche, L. Drake, 1995, Journal of the American Academy of Dermatology.

Topical therapies in hyperhidrosis care.

D. Pariser, Angela Ballard, 2014, Dermatologic clinics.

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial.

A. Lucky, R. Pariser, D. Pariser, 2003, Journal of the American Academy of Dermatology.

Iontophoresis for palmar and plantar hyperhidrosis.

D. Pariser, Angela Ballard, 2014, Dermatologic clinics.

Cosmetic procedures we all perform.

R. Pariser, D. Pariser, P. Phillips, 1994, Cutis.

Intravenous desensitization to mechlorethamine in patients with psoriasis.

J. Taylor, D. Pariser, K. Halprin, 1976, Archives of dermatology.

Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study.

D. Pariser, C. Schmitz, L. Green, 2019, The Journal of clinical and aesthetic dermatology.

Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability

D. Pariser, L. Stein Gold, E. Guenin, 2019, Journal of drugs in dermatology : JDD.

Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.

S. Tyring, L. Kircik, D. Pariser, 2018, Journal of drugs in dermatology : JDD.

Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris

A. Grada, D. Pariser, C. Schmitz, 2020 .

Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.

Susan C. Taylor, L. Baumann, A. Menter, 2003, Cutis.

Guidelines of care for vitiligo. American Academy of Dermatology.

M. Turner, J. Nordlund, E. Farmer, 1996, Journal of the American Academy of Dermatology.

Guidelines of care for chemical peeling

M. Turner, S. Salasche, L. Drake, 1995 .

A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads.

Susan C. Taylor, L. Baumann, A. Menter, 2005, Journal of drugs in dermatology : JDD.

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris.

D. Pariser, P. Rich, F. Cook-Bolden, 2014, Journal of drugs in dermatology : JDD.

Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial.

J. Herndon, Y. Poulin, D. Thiboutot, 2006, Journal of the American Academy of Dermatology.

The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle.

D. Thiboutot, T. Jones, S. Clark, 2005, Cutis.

A novel targeted T-cell modulator, efalizumab, for plaque psoriasis.

M. Lebwohl, S. Tyring, P. Walicke, 2003, The New England journal of medicine.

Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

A. Menter, M. Gooderham, K. Papp, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis.

J. Weiss, H. Haines, R. Pariser, 1999, Journal of the American Academy of Dermatology.

Understanding Patient Experience With Hyperhidrosis: A National Survey of 1,985 Patients.

D. Pariser, A. Hebert, D. Glaser, 2018, Journal of drugs in dermatology : JDD.

Prevalence of Multifocal Primary Hyperhidrosis and Symptom Severity Over Time: Results of a Targeted Survey

D. Pariser, D. Glaser, Angela Ballard, 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Efficacy and Safety of Topical Sofpironium Bromide Gel for the Treatment of Axillary Hyperhidrosis: A Phase II, Randomized, Controlled, Double-Blinded Trial.

Ping-Yu Liu, L. Baumann, Joel L Cohen, 2020, Journal of the American Academy of Dermatology.

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

J. Ho, L. Ferris, K. Covington, 2018, BMC Cancer.

The use of photodynamic therapy in dermatology: results of a consensus conference.

J. Carruthers, R. Anderson, D. Rigel, 2006, Journal of drugs in dermatology : JDD.

EFFICACY AND SAFETY OF APREMILAST IN PATIENTS WITH MILD TO MODERATE PLAQUE PSORIASIS: RESULTS OF A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.

M. Gooderham, K. Papp, D. Pariser, 2021, Journal of the American Academy of Dermatology.

From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis

A. Gottlieb, M. Lebwohl, A. Armstrong, 2017, Journal of the American Academy of Dermatology.

Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST).

C. Leonardi, Zhenyi Xu, D. Pariser, 2015, Journal of drugs in dermatology : JDD.

Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials

J. Drew, D. Pariser, A. Hebert, 2018, Pediatric dermatology.

A Prospective, Nonrandomized, Open‐Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis

M. Brin, D. Pariser, A. Hebert, 2015, Pediatric dermatology.

Randomized, Double‐Blind, Placebo‐Controlled Study Evaluating the Lidocaine/Tetracaine Patch for Induction of Local Anesthesia prior to Minor Dermatologic Procedures in Geriatric Patients

N. Sadick, R. Pariser, D. Pariser, 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Self‐Warming Lidocaine/Tetracaine Patch Effectively and Safely Induces Local Anesthesia during Minor Dermatologic Procedures

B. Berman, R. Pariser, D. Pariser, 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Serlopitant for Psoriatic Pruritus: a Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

M. Lebwohl, M. Spellman, G. Yosipovitch, 2020, Journal of the American Academy of Dermatology.

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial†

Kelly N. Taylor, Constance M. Brown, B. Elewski, 2019, The British journal of dermatology.

Guidelines of care for soft tissue augmentation: collagen implants. American Academy of Dermatology.

E. Farmer, L. Drake, R. Goltz, 1996, Journal of the American Academy of Dermatology.

Guidelines of care for soft tissue augmentation: fat transplantation. American Academy of Dermatology.

E. Farmer, L. Drake, R. Goltz, 1996, Journal of the American Academy of Dermatology.

Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies.

M. Lebwohl, J. Silverberg, A. Paller, 2017, The journal of allergy and clinical immunology. In practice.

Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis.

J. Weiss, R. Pariser, D. Pariser, 1995, Clinical therapeutics.

Randomized Vehicle-Controlled Study of Short Drug Incubation Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses of the Face or Scalp

D. Pariser, J. Berg, M. Ferdon, 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug

N. Sadick, Z. Draelos, M. Gold, 2021, American Journal of Clinical Dermatology.

Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study.

R. Geronemus, D. Pariser, W. Abramovits, 2008, Journal of the American Academy of Dermatology.

A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.

M. Lebwohl, J. Koo, D. Wenkert, 2013, Journal of the American Academy of Dermatology.

Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials.

J. Wohlrab, K. Papp, H. Valdez, 2016, Journal of drugs in dermatology : JDD.

Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.

B. Strober, A. Kimball, C. Conrad, 2022, The British journal of dermatology.

Scanning Electron Microscopic Hair Shaft Analysis in Ectodermal Dysplasia Syndromes

D. Pariser, A. Hood, Judith V. Williams, 2015, Pediatric dermatology.

Light Microscopic Hair Shaft Analysis in Ectodermal Dysplasia Syndromes

D. Pariser, Judith V. Williams, Stefanie A. Hirano, 2012, Pediatric dermatology.

Techniques for Diagnosing Skin and Hair Disease

W. Eaglstein, D. Pariser, R. J. Caserio, 1986 .

WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR]).

A. Gottlieb, L. Naldi, K. Papp, 2015, Journal of the American Academy of Dermatology.

Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open‐label, multicenter, Phase IIIb study

A. Menter, P. Kwon, D. Toth, 2007, International journal of dermatology.

Primary isolation of Neisseria gonorrhoeae on hemoglobin-free Thayer-Martin medium.

D. Pariser, W. Pittard, 1970, Public health reports.

AAD consensus statement on psoriasis therapies.

M. Lebwohl, J. Callen, M. Weinblatt, 2003, Journal of the American Academy of Dermatology.

Treating psoriasis patients with biologic agents.

D. Pariser, 2003, Managed care.

A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne.

J. Strauss, J. Leyden, L. Drake, 2001, Journal of the American Academy of Dermatology.

A double-blinded, randomized, vehicle-controlled, multicenter, parallel-group study to assess the safety and efficacy of tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adults.

A. Fleischer, J. Leyden, D. Thiboutot, 2007, Cutis.

Guidelines of care for soft tissue augmentation: gelatin matrix implant. American Academy of Dermatology.

E. Farmer, L. Drake, R. Goltz, 1996, Journal of American Academy of Dermatology.

Basal cell carcinoma: when to treat it yourself, and when to refer.

D. Pariser, P. Phillips, P. K. Phillips, 1994, Geriatrics.

The electric field near human skin wounds declines with age and provides a noninvasive indicator of wound healing

R. Nuccitelli, D. Pariser, Pamela Nuccitelli, 2011, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices.

N. Zeitouni, D. Siegel, R. Ceilley, 2021, The Journal of clinical and aesthetic dermatology.

Mycosis fungoides involving the brain and optic nerves.

D. Pariser, 1978, Archives of dermatology.

OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results.

A. Kimball, K. Rothman, A. Menter, 2015, Journal of the American Academy of Dermatology.

Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity

L. Nelson, J. Drew, S. Fehnel, 2019, Journal of Patient-Reported Outcomes.

Capitation for dermatologists.

D. Pariser, 1996, Archives of dermatology.

Validation of the Dermatology Life Quality Index and the Work Productivity and Activity Impairment-Chronic Hand Dermatitis questionnaire in chronic hand dermatitis.

P. Lavin, D. Pariser, K. Kahler, 2003, Journal of the American Academy of Dermatology.

Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial

M. Lebwohl, M. Gooderham, K. Papp, 2022, American Journal of Clinical Dermatology.

Management of moderate to severe plaque psoriasis with biologic therapy.

D. Pariser, David M Pariser, 2003, Managed care.

Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)

L. Nelson, D. Margolis, T. Bieber, 2019, Current medical research and opinion.

Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.

J. Strauss, J. Leyden, L. Drake, 2001, Journal of the American Academy of Dermatology.

Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis

E. Simpson, M. Boguniewicz, L. Eckert, 2019, BMC Dermatology.

Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis

Yang Zhao, A. Gottlieb, S. Feldman, 2021, The Journal of dermatological treatment.

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.

S. Forman, C. Lynde, L. Kircik, 2023, JAMA dermatology.

PBI34 PREDICTIVE VALUE OF EARLY PASI RESPONSE TO TILDRAKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS

Yang Zhao, A. Gottlieb, S. Feldman, 2019, Value in Health.

A Survey of Community Dermatologists Reveals the Unnecessary Impact of Trial-and-Error Behavior on the Psoriasis Biologic Treatment Paradigm

B. Strober, M. Lebwohl, A. Menter, 2021, Dermatologic Therapy.

Clinical Efficacy of Efalizumab in Patients With Chronic Plaque Psoriasis: Results From Three Randomized Placebo-Controlled Phase III Trials: Part I

M. Lebwohl, P. Kwon, K. Papp, 2005, Journal of cutaneous medicine and surgery.

Interim Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes

P. A. Montgomery, B. Strober, Sepideh Parhami, 2022, SKIN The Journal of Cutaneous Medicine.

Greater Efficacy with Secukinumab Treatment is Associated with Greater Psoriasis Symptom Relief: Results from Secukinumab Clinical Trial Data

B. Strober, Yang Zhao, L. McLeod, 2017 .

Roflumilast Cream 0.3% Improved the Severity and Impact of Itch in Patients With Chronic Plaque Psoriasis in the Phase 3 DERMIS-1 and DERMIS-2 Studies

M. Lebwohl, M. Gooderham, K. Papp, 2021, SKIN The Journal of Cutaneous Medicine.

Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials

M. Lebwohl, Z. Draelos, M. Gooderham, 2021, SKIN The Journal of Cutaneous Medicine.

Safety and Efficacy of Escalating Doses of Ingenol Mebutate for Field Treatment of Actinic Keratosis on the Full Face, Full Balding Scalp, or Chest.

N. Swanson, T. Skov, D. Siegel, 2017, Journal of drugs in dermatology : JDD.

Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Enhanced Lotion Formulation of Halobetasol Propionate, 0.05% Versus Its Vehicle in Adult Subjects With Plaque Psoriasis.

D. Pariser, E. Tschen, S. Kempers, 2017, Journal of drugs in dermatology : JDD.

A Randomized, Vehicle-Controlled Phase 3 Study of Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses on the Upper Extremities.

D. Piacquadio, S. Marcus, D. Pariser, 2019, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Guidelines of care for dermatomyositis. American Academy of Dermatology.

J. Callen, E. Farmer, L. Drake, 1996, Journal of the American Academy of Dermatology.

Adapalene 0.1% and benzoyl peroxide 2.5% combination gel for the treatment of acne vulgaris

D. Pariser, 2010 .

Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.

R. Gottschalk, D. Pariser, Luz E. Colón, 2008, Journal of drugs in dermatology : JDD.

Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.

Susan C. Taylor, D. Pariser, W. Piette, 2008, Archives of dermatology.

Topical steroids: a guide for use in the elderly patient.

D. Pariser, 1991, Geriatrics.

003 Crisaborole ointment improves global atopic dermatitis severity: Pooled results from two phase 3 clinical trials

J. Fowler, R. Sidbury, D. Pariser, 2017 .

Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate‐to‐severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials

M. Lebwohl, D. Pariser, R. Israel, 2018, Journal of the American Academy of Dermatology.

Safety and Efficacy of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination Lotion in the Treatment of Moderate-to-severe Plaque Psoriasis: A Comparison with Halobetasol Propionate 0.05% Cream.

L. Kircik, D. Pariser, N. Bhatia, 2018, The Journal of clinical and aesthetic dermatology.

Long‐term safety results from a phase 3 open‐label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in moderate‐to‐severe plaque psoriasis

M. Lebwohl, D. Pariser, R. Israel, 2019, Journal of the American Academy of Dermatology.

A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis

J. Drew, A. Nast, D. Pariser, 2019, American Journal of Clinical Dermatology.

Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects With Primary Focal Hyperhidrosis.

R. M. Rubison, D. Pariser, T. Tremblay, 2017, Journal of drugs in dermatology : JDD.

Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials

J. Drew, D. Pariser, J. Quiring, 2018, American Journal of Clinical Dermatology.

THE PRACTICAL USE OF INFLIXIMAB IN THE OFFICE : AS-OBSERVED DATA FROM ONE DERMATOLOGIST ’ S EXPERIENCE

B. Strober, A. Kimball, C. Leonardi, 2007 .

Guidelines of care for nevi. II. Nonmelanocytic nevi, hamartomas, neoplasms, and potentially malignant lesions. Committee on Guidelines of Care.

S. Salasche, L. Drake, R. Ceilley, 1995, Journal of the American Academy of Dermatology.

The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoriasis Vulgaris: Results from the Randomized PSO-FAST Study.

C. Leonardi, Zhenyi Xu, D. Pariser, 2016, Journal of drugs in dermatology : JDD.

The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score

B. Strober, M. Lebwohl, K. Papp, 2021, Dermatology and Therapy.

Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.

M. Lebwohl, A. Menter, A. Balin, 2007, Journal of drugs in dermatology : JDD.

Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled study.

M. Lebwohl, H. Moss, R. Pariser, 1996, Archives of dermatology.

Evidence‐ and consensus‐based (S3) Guidelines for the Treatment of Actinic Keratosis – International League of Dermatological Societies in cooperation with the European Dermatology Forum – Short version

S. Shumack, H. Kerl, N. Swanson, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis

D. Mould, J. Drew, D. Pariser, 2021, Clinical Pharmacokinetics.

Mentor's Introduction

D. Pariser, 2001 .

A Machine Learning-Based Test for Predicting Response to Psoriasis Biologics

A. Menter, T. Dickerson, Byung-in Lee, 2021, SKIN The Journal of Cutaneous Medicine.

27434 Early trends of disease improvement in adult patients with atopic dermatitis treated with dupilumab: Real-world data from the PROSE registry

G. Yosipovitch, R. Lin, D. Pariser, 2021 .

Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination.

L. Kircik, D. Pariser, L. Stein Gold, 2018, Journal of drugs in dermatology : JDD.

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.

B. Elewski, J. Leyden, Sewon Kang, 1998, Journal of the American Academy of Dermatology.

Botulinum toxin in the management of focal hyperhidrosis

D. Pariser, D. Glaser, 2011 .

Guidelines of care for cutaneous lupus erythematosus. American Academy of Dermatology.

J. Callen, E. Farmer, L. Drake, 1996, Journal of the American Academy of Dermatology.

Scanning Electron Microscopic Hair Shaft Analysis in Ectodermal Dysplasia Syndromes

D. Pariser, A. Hood, Judith V. Williams, 2015, Pediatric dermatology.

Management of moderate to severe plaque psoriasis with biologic therapy.

D. Pariser, 2003, Managed care.

Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study.

F. Kianifard, A. Blauvelt, S. Tyring, 2023, Journal of dermatological science.

Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis on Behalf of the Multi-specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis

Kevin Grimes, John Hornberger, Dee Anna Glaser, 2022 .

Evidence and consensus based (S3) Guidelines for the Treatment of Actinic Keratosis

H.-J. Röwert-Huber, D. Pariser, O. Sangueza, 2015 .

Facial soft-tissue fillers conference: assessing the state of the science.

Susan C. Taylor, Rod J. Rohrich, J. Carruthers, 2011, Plastic and reconstructive surgery.

Etanercept treatment for children and adolescents with plaque psoriasis.

A. Gottlieb, A. Paller, R. Langley, 2008, The New England journal of medicine.

P. Schlievert, R. Langley, D. Leung, 2009, The British journal of dermatology.